Hungarian Investment Promotion Agency

Swiss-owned Novartis expands its Hungarian presence by adding a regional R&D center. Apart from its core research functions, the facility will play a crucial role in coordinating related activities in several countries.

2023. 05. 05.

As part of the continuation of a series of large-scale developments since 2019, leading pharmaceutical giant Egis Gyógyszergyár Zrt. now invests EUR 21.1 million in Körmend to install new technology, increase capacity and enhance efficiency. The investment is ...

2022. 06. 17.

Becton Dickinson (BD), one of the world’s leading medical technology companies, announced an investment of 210 million dollars that amounts to nearly one-fifth of its global development budget earmarked for the upcoming years. The project, which will create mo...

2022. 03. 01.

Ceva Phylaxia, one of the world's leading animal vaccine producing companies, will set up a new vaccine factory along with the associated infrastructure by developing a new site under a greenfield investment in Hungary. With the technology-intensive investment o...

2021. 11. 23.

In order to increase their pharmaceutical production capacity, the French-owned Egis Pharmaceuticals has expanded its site in Körmend. With the investment of more than EUR 21.8 million, in addition to the new packaging factory, Egis has also established a plant ...

2021. 10. 15.

25-year-old SCHOTT Hungary, owned by the German Carl Zeiss Foundation, is launching an investment project on its site in Lukácsháza. 16 items of highly-automated, new generation, Industry 4.0 production lines will be put in service in the pharmaceutical glass ...

2020. 12. 04.